Your browser doesn't support javascript.
loading
Corrected Allele Frequency of BRCA1/2 Mutations Is an Independent Prognostic Factor for Treatment Response to PARP-Inhibitors in Ovarian Cancer Patients.
Grech, Christina T; Pils, Dietmar; Aust, Stefanie; Grimm, Christoph; Polterauer, Stephan; Reinthaller, Alexander; Müllauer, Leonhard; Reischer, Theresa; Bekos, Christine.
Afiliación
  • Grech CT; Department of Obstetrics and Gynecology, Division of General Gynecology and Gynecologic Oncology, Gynecologic Cancer Unit, Comprehensive Cancer Center (CCC), Medical University of Vienna, 1090 Vienna, Austria.
  • Pils D; Department of General Surgery, Division of Visceral Surgery, Comprehensive Cancer Center (CCC) Vienna, Medical University of Vienna, 1090 Vienna, Austria.
  • Aust S; Department of General Surgery, Division of Visceral Surgery, Comprehensive Cancer Center (CCC) Vienna, Medical University of Vienna, 1090 Vienna, Austria.
  • Grimm C; Department of Obstetrics and Gynecology, Division of General Gynecology and Gynecologic Oncology, Gynecologic Cancer Unit, Comprehensive Cancer Center (CCC), Medical University of Vienna, 1090 Vienna, Austria.
  • Polterauer S; Department of Obstetrics and Gynecology, Division of General Gynecology and Gynecologic Oncology, Gynecologic Cancer Unit, Comprehensive Cancer Center (CCC), Medical University of Vienna, 1090 Vienna, Austria.
  • Reinthaller A; Department of Obstetrics and Gynecology, Division of General Gynecology and Gynecologic Oncology, Gynecologic Cancer Unit, Comprehensive Cancer Center (CCC), Medical University of Vienna, 1090 Vienna, Austria.
  • Müllauer L; Department of Obstetrics and Gynecology, Division of General Gynecology and Gynecologic Oncology, Gynecologic Cancer Unit, Comprehensive Cancer Center (CCC), Medical University of Vienna, 1090 Vienna, Austria.
  • Reischer T; Department of Pathology, Medical University of Vienna, 1090 Vienna, Austria.
  • Bekos C; Department of Obstetrics and Gynecology, Division of General Gynecology and Gynecologic Oncology, Gynecologic Cancer Unit, Comprehensive Cancer Center (CCC), Medical University of Vienna, 1090 Vienna, Austria.
J Pers Med ; 12(9)2022 Sep 07.
Article en En | MEDLINE | ID: mdl-36143252
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: J Pers Med Año: 2022 Tipo del documento: Article País de afiliación: Austria
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: J Pers Med Año: 2022 Tipo del documento: Article País de afiliación: Austria